"Designing Growth Strategies is in our DNA"

Anticoagulants Market Size, Share, Trends & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2032

Last Updated: March 31, 2025 | Format: PDF | Report ID: FBI101807

 

Anticoagulants Market

Request Now
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Major Cardiovascular Diseases by Key Countries
    2. Overview of Novel Oral Anticoagulants (NOACs)
    3. Pipeline Analysis
    4. Key Industry Developments Such as Mergers & Acquisitions
    5. New Product Launches
    6. Regulatory Scenario in Key Countries
    7. Reimbursement Scenario by Key Countries
  5. Global Anticoagulants Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Pulmonary Embolism (PE)
      2. Deep Vein Thrombosis (DVT)
      3. Atrial Fibrillation
      4. Heart Attacks
      5. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injectable
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Anticoagulants Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Pulmonary Embolism (PE)
      2. Deep Vein Thrombosis (DVT)
      3. Atrial Fibrillation
      4. Heart Attacks
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Anticoagulants Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Pulmonary Embolism (PE)
      2. Deep Vein Thrombosis (DVT)
      3. Atrial Fibrillation
      4. Heart Attacks
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Anticoagulants Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Pulmonary Embolism (PE)
      2. Deep Vein Thrombosis (DVT)
      3. Atrial Fibrillation
      4. Heart Attacks
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Anticoagulants Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Pulmonary Embolism (PE)
      2. Deep Vein Thrombosis (DVT)
      3. Atrial Fibrillation
      4. Heart Attacks
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Anticoagulants Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Pulmonary Embolism (PE)
      2. Deep Vein Thrombosis (DVT)
      3. Atrial Fibrillation
      4. Heart Attacks
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
      1. Bristol-Myers Squibb Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability))
      2. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability))
      3. Bayer AG
        1. Overview,  
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability))
      4. Janssen Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability))
      5. Eisai Co., Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability))
      6. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability))
  12. Strategic Recommendations
Read Less

Figure 1:  Global Anticoagulants Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Anticoagulants Market Value Share (%), by Disease Indication, 2018 & 2026

Figure 3:  Global Anticoagulants Market Forecast (US$ Mn), by Pulmonary Embolism (PE), 2015-2026

Figure 4:  Global Anticoagulants Market Forecast (US$ Mn), by Deep Vein Thrombosis (DVT), 2015-2026

Figure 5:  Global Anticoagulants Market Forecast (US$ Mn), by Atrial Fibrillation, 2015-2026

Figure 6:  Global Anticoagulants Market Forecast (US$ Mn), by Heart Attacks, 2015-2026

Figure 7:  Global Anticoagulants Market Forecast (US$ Mn), by Others, 2015-2026

Figure 8:  Global Anticoagulants Market Value Share (%), by Route of Administration, 2018 & 2026

Figure 9:  Global Anticoagulants Market Forecast (US$ Mn), by Oral, 2015-2026

Figure 10:  Global Anticoagulants Market Forecast (US$ Mn), by Injectable, 2015-2026

Figure 11:  Global Anticoagulants Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 12:  Global Anticoagulants Market Forecast (US$ Mn), by Hospitals Pharmacies, 2015-2026

Figure 13:  Global Anticoagulants Market Forecast (US$ Mn), by Retail Pharmacies, 2015-2026

Figure 14:  Global Anticoagulants Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 15:  Global Anticoagulants Market Forecast (US$ Mn), by Others, 2015-2026

Figure 16:  Global Anticoagulants Market Value (US$ Mn), by Region, 2018 & 2026

Figure 17:  North America Anticoagulants Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 18:  North America Anticoagulants Market Value Share (%), by Disease Indication, 2018

Figure 19:  North America Anticoagulants Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 20:  North America Anticoagulants Market Value Share (%), by Route of Administration, 2018

Figure 21:  North America Anticoagulants Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 22:  North America Anticoagulants Market Value Share (%), by Distribution Channel, 2018

Figure 23:  North America Anticoagulants Market Value (US$ Mn), By Country, 2018 & 2026

Figure 24:  North America Anticoagulants Market Value Share (%), By Country, 2018

Figure 25:  Europe Anticoagulants Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 26:  Europe Anticoagulants Market Value Share (%), by Disease Indication, 2018

Figure 27:  Europe Anticoagulants Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 28:  Europe Anticoagulants Market Value Share (%), by Route of Administration, 2018

Figure 29:  Europe Anticoagulants Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 30:  Europe Anticoagulants Market Value Share (%), by Distribution Channel, 2018

Figure 31:  Europe Anticoagulants Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 32:  Europe Anticoagulants Market Value Share (%), By Country/ Sub-region, 2018

Figure 33:  Asia Pacific Anticoagulants Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 34:  Asia Pacific Anticoagulants Market Value Share (%), by Disease Indication, 2018

Figure 35:  Asia Pacific Anticoagulants Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 36:  Asia Pacific Anticoagulants Market Value Share (%), by Route of Administration, 2018

Figure 37:  Asia Pacific Anticoagulants Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 38:  Asia Pacific Anticoagulants Market Value Share (%), by Distribution Channel, 2018

Figure 39:  Asia Pacific Anticoagulants Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 40:  Asia Pacific Anticoagulants Market Value Share (%), By Country/ Sub-region, 2018

Figure 41:  Latin America Anticoagulants Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 42:  Latin America Anticoagulants Market Value Share (%), by Disease Indication, 2018

Figure 43:  Latin America Anticoagulants Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 44:  Latin America Anticoagulants Market Value Share (%), by Route of Administration, 2018

Figure 45:  Latin America Anticoagulants Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 46:  Latin America Anticoagulants Market Value Share (%), by Distribution Channel, 2018

Figure 47:  Latin America Anticoagulants Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 48:  Latin America Anticoagulants Market Value Share (%), By Country/ Sub-region, 2018

Figure 49:  Middle East & Africa Anticoagulants Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 50:  Middle East & Africa Anticoagulants Market Value Share (%), by Disease Indication, 2018

Figure 51:  Middle East & Africa Anticoagulants Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 52:  Middle East & Africa Anticoagulants Market Value Share (%), by Route of Administration, 2018

Figure 53:  Middle East & Africa Anticoagulants Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 54:  Middle East & Africa Anticoagulants Market Value Share (%), by Distribution Channel, 2018

Figure 55:  Middle East & Africa Anticoagulants Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 56:  Middle East & Africa Anticoagulants Market Value Share (%), By Country/ Sub-region, 2018

Figure 57:  Global Anticoagulants Market Share (%), By Company, 2018

Table 1:  Global Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015–2026

Table 2:  Global Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015–2026

Table 3:  Global Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Anticoagulants Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 6:  North America Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 7:  North America Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Anticoagulants Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 10:  Europe Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 11:  Europe Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Anticoagulants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 14:  Asia Pacific Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 15:  Asia Pacific Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Anticoagulants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Latin America Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 18:  Latin America Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 19:  Latin America Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Latin America Anticoagulants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Middle East & Africa Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 22:  Middle East & Africa Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 23:  Middle East & Africa Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 24:  Middle East & Africa Anticoagulants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Anticoagulants Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Consulting Services
    How will you benefit from our consulting services ?